C10BX09 • rosuvastatin + amlodipine • Cardiovascular system | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs
Rosuvastatin+amlodipine is a combination medication used for the treatment of dyslipidemia and hypertension. Rosuvastatin is an HMG-CoA reductase inhibitor that lowers LDL cholesterol and triglycerides while increasing HDL cholesterol. Amlodipine is a calcium channel blocker that relaxes blood vessels and lowers blood pressure.
This combination is taken orally, usually once daily, and is indicated for patients requiring both lipid and blood pressure control. It is commonly used to reduce overall cardiovascular risk, including the risk of myocardial infarction and stroke.
Common side effects include headache, dizziness, nausea, and muscle pain. In rare cases, severe adverse reactions such as kidney failure or rhabdomyolysis may occur. Regular monitoring of renal function, blood pressure, and lipid profile is essential.
Rosuvastatin+amlodipine is an effective therapeutic option for patients at high cardiovascular risk, offering multiple benefits in a single administration.
Substance: rosuvastatin + amlodipine
Date of last drug list: 01-01-2016
Commercial code: W62262008
Concentration: 10mg / 10mg
Pharmaceutical form: tablets
Quantity: 100
Product type: generic
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.